重症患者支气管肺泡灌洗的获益-风险平衡:前瞻性多中心队列研究
该前瞻性多中心队列研究在16个ICU连续纳入483例成人患者共483次支气管肺泡灌洗(BAL),前瞻性收集操作中或操作后24小时内不良事件。67例(13.9%)发生至少3级不良事件(需治疗干预,包括调整呼吸支持)。非插管患者中,由经验不足医师(非呼吸科医师,或专科年限少于10年或BAL操作少于50例的重症医师)操作是耐受不良的主要预测因素(OR 3.57,95%CI 1.04-12.35;P=0.04)。仅227例(47.0%)BAL结果对决策有满意帮助,且无法用回归模型预测。作者认为ICU患者行BAL需极度谨慎,经验不足医师操作时须有人陪同。
要点
- 16个ICU共483例患者行BAL,67例(13.9%)发生至少3级不良事件,需治疗干预包括调整呼吸支持。
- 非插管患者中,经验不足医师操作是BAL耐受不良的主要预测因素(OR 3.57,95%CI 1.04-12.35;P=0.04)。
- 仅227例(47.0%)BAL对决策有满意帮助(允许中断或启动一项或多项治疗),且无法用回归模型预测。
- 作者认为ICU患者行BAL需极度谨慎,经验不足医师操作时须有人陪同。
适用人群与场景
- 16个ICU连续纳入的成人患者,共483例、483次BAL;年龄63岁(IQR 53-72),女性162例(33.5%),简化急性生理评分II 48(IQR 37-61),免疫抑制244例(50.5%)。
- BAL在非插管患者中开始的有105例(21.7%)。
诊断标准与关键阈值
- 不良事件分级:至少3级为需要治疗干预(包括调整呼吸支持)的临床不良事件,定义为BAL耐受不良。
- BAL对决策有满意帮助定义为允许中断或启动一项或多项治疗。
- 经验不足医师定义为非呼吸科医师,或专科年限少于10年或BAL操作少于50例的重症医师。
红旗征与不能漏的情况
- BAL操作中或操作后24小时内发生至少3级不良事件(需治疗干预,包括调整呼吸支持)提示BAL耐受不良。
研究设计与关键结果
- 研究类型:前瞻性多中心队列研究,16个ICU,483例患者共483次BAL。
- 主要结果:67例(13.9%)发生至少3级不良事件。
- 非插管患者中,经验不足医师操作是BAL耐受不良的主要预测因素(OR 3.57,95%CI 1.04-12.35;P=0.04)。
- BAL对决策有满意帮助227例(47.0%),且无法用回归模型预测。
证据类型、等级与局限
- 证据类型:前瞻性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU患者考虑行BAL时需极度谨慎,经验不足医师操作时须有人陪同。
- 非插管患者行BAL时,操作者经验不足与耐受不良相关,需关注操作者资质。
- BAL结果对决策的帮助无法事先预测,近半数(47.0%)对决策有满意帮助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To assess the benefit-to-risk balance of bronchoalveolar lavage (BAL) in intensive care unit (ICU) patients.
METHODS: In 16 ICUs, we prospectively collected adverse events during or within 24 h after BAL and assessed the BAL input for decision making in consecutive adult patients. The occurrence of a clinical adverse event at least of grade 3, i.e., sufficiently severe to need therapeutic action(s), including modification(s) in respiratory support, defined poor BAL tolerance. The BAL input for decision making was declared satisfactory if it allowed to interrupt or initiate one or several treatments.
RESULTS: We included 483 BAL in 483 patients [age 63 years (interquartile range (IQR) 53-72); female gender: 162 (33.5%); simplified acute physiology score II: 48 (IQR 37-61); immunosuppression 244 (50.5%)]. BAL was begun in non-intubated patients in 105 (21.7%) cases. Sixty-seven (13.9%) patients reached the grade 3 of adverse event or higher. Logistic regression showed that a BAL performed by a non-experienced physician (non-pulmonologist, or intensivist with less than 10 years in the specialty or less than 50 BAL performed) was the main predictor of poor BAL tolerance in non-intubated patients [OR: 3.57 (95% confidence interval 1.04-12.35); P = 0.04]. A satisfactory BAL input for decision making was observed in 227 (47.0%) cases and was not predictable using logistic regression.
CONCLUSIONS: Adverse events related to BAL in ICU patients are not infrequent nor necessarily benign. Our findings call for an extreme caution, when envisaging a BAL in ICU patients and for a mandatory accompaniment of the less experienced physicians.
参考来源
- Kamel T, Helms J, Janssen-Langenstein R, et al. Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study. Intensive Care Med. 2020. PMID: 31912201. doi:10.1007/s00134-019-05896-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。